Li, Zhixiu; Khan, Mohammad K; Villiger, Peter M.; van der Linden, Sjef; Brown, Matthew A; Khan, Muhammad A (2022). Reply to Niv Ben-Shabat: Mortality in AS according to treatment. Arthritis care & research, 74(12), pp. 2120-2121. Wiley 10.1002/acr.24773
|
Text
Arthritis_Care_Research_-_2021_-_Li_-_Reply_to_Niv_Ben_2010Shabat_Mortality_in_AS_according_to_treatment.pdf - Accepted Version Available under License Publisher holds Copyright. Download (1MB) | Preview |
We read with great interest the article by Niv Ben-Shabat et al. in Arthritis Care and Research titled "Mortality in ankylosing spondylitis according to treatment: a nationwide retrospective cohort study of 5900 patients from Israel" (1). The study concludes that ankylosing spondylitis (AS) is associated with reduced life expectancy, but not amongst the small subgroup of AS patients treated with TNF-inhibitors. We have concerns regarding the study design and analyses that underpin these findings.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology |
UniBE Contributor: |
Villiger, Peter Matthias |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2151-4658 |
Publisher: |
Wiley |
Language: |
English |
Submitter: |
Brigitte Isenschmid |
Date Deposited: |
15 Dec 2021 15:15 |
Last Modified: |
20 Dec 2022 00:11 |
Publisher DOI: |
10.1002/acr.24773 |
PubMed ID: |
34437771 |
BORIS DOI: |
10.48350/161667 |
URI: |
https://boris.unibe.ch/id/eprint/161667 |
Actions (login required)
 |
Edit item |